OIMU
UTHR icon

Osmosis Investment Management UK’s United Therapeutics UTHR Stock Holding History

Osmosis Investment Management UK’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$430K Sell
794
-818
-51% -$461K 0.02% 376
2026
Q1 		$956K Buy
+1,612
New +$803K 0.03% 331

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Osmosis Investment Management UK's UTHR Position: Q2 2026 in Review

Osmosis Investment Management UK reduced its United Therapeutics (UTHR) stake by 51% in Q2 2026, selling an estimated $461K and leaving 794 shares worth $430K. The position accounts for 0.02% of the portfolio, ranked #376.

Osmosis Investment Management UK first reported a position in UTHR in Q1 2026 and has held it in 2 quarters since. The position peaked at $956K in Q1 2026. 878 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Osmosis Investment Management UK held 794 shares of United Therapeutics worth $430K as of Q2 2026.
  • Osmosis Investment Management UK sold 818 United Therapeutics shares in Q2 2026, an estimated $461K.
  • United Therapeutics made up 0.02% of Osmosis Investment Management UK's portfolio in Q2 2026, its #376 holding.
  • Osmosis Investment Management UK first reported a position in United Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • Osmosis Investment Management UK's United Therapeutics position peaked at $956K in Q1 2026.
  • 878 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Osmosis Investment Management UK's 13F filing for Q2 2026, filed 13 Aug 2026.